10/20/2026
UnitedHealth cleared more than $4 billion in a single quarter and raised its forecast. Competitive markets do not produce numbers like that.
Competition grinds margin down. A rival prices under you and the fat erodes. That did not happen here, and the reason is built into the structure. Medicare Advantage, Medicaid managed care, and the pharmacy benefit business run on government contracts and government rules, not on a customer who shops on price.
The patient rarely pays the insurer directly and almost never sees the number. Wall the buyer off from the price and the price holds.
In the same week UnitedHealth reported that profit, Pennsylvania sued the three largest pharmacy middlemen over insulin pricing. Those three control roughly 80 percent of that market. One of them, OptumRx, is a UnitedHealth company.
The spread a state now calls a scheme and the margin UnitedHealth just reported are the same dollars counted from two ends.
The squeeze physicians feel is a closed market protecting the people who wrote its rules.
A free market would have erased that $4 billion years ago. It is still sitting there because the market was never free.